ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
2017年03月08日 10時00分
Source:
Cenegenics Elite Health
Cenegenics Elite Health Expands Globally and Attracts Physicians From Around the World
ネバダ州ラスベガス, 2017年03月08日 - (JCN Newswire) - With 20 national Centers and two international Centers, the world's largest Age Management medical practice is expanding to include more global markets. Cenegenics Elite Heath, which specializes in precision medicine including Genetics, nutrition, exercise and bio-identical hormone optimization, is actively seeking physicians to open more Centers in Europe, Asia, the Middle East, Australia, Canada, Africa, and Latin America.
Cenegenics International is offering licensing agreements to physicians who are interested in opening Centers overseas. The company is providing a turn-key solution with full support in the clinical and business model. "There's a clear worldwide trend towards preventive medicine, says Mario Garcia, the Director of Cenegenics International," and now is the perfect time for our company, which has always been the leader in Age Management Medicine, to present a proven successful business model for physicians interested in broadening their medical practice with clinically proven evidence-based protocols."
The success of the Cenegenics program, which has helped over 40,000 patients globally, is rooted in science-based medicine which prevents chronic aging and its symptoms. The life-changing program is built on precision medical care that incorporates low-glycemic and anti-inflammatory nutrition, exercise, nutraceutical supplementation and hormone optimization. No single element stands alone, the Cenegenics program is a symphony. Its effect keeps the body in perfect harmony and supports optimum health goals, and a life filled with vitality, physical fitness, mental acuity, energy, and a heightened sense of well-being. Additionally, the evaluation processes help identify disease risks and create a proactive plan that works to move the patient into the lowest possible risk categories for disease.
Attracting experienced physicians is key to the company's success. In fact, Cenegenics' doctors are among the best in the world, subscribing to the philosophy of disease prevention rather than the treatment of illnesses after they occur. "After 20 years of leading Age Management and Precision Medicine, Cenegenics is excited to expand internationally and have the opportunity to partner with leading physicians around the world," says Cenegenics International Medical Director, Dr. Claudia Villate. "Through our international network of physicians, we will now be able to help more patients than ever achieve their highest level of health despite getting older."
Cenegenics is not only the world leader in Age-Management Medicine; it continues to uncover the latest medical advances to prevent aging through the Cenegenics Education and Research Foundation (CERF). Championed by an elite team of physician educators and researchers, CERF's mission is to conduct research and provide evidence-based education in age management and preventive medicine.
To interested physicians, the Cenegenics training and certification is conducted in English therefore, it's important to be able to speak and read it somewhat fluently. For more information go to:
https://cenegenics.com/cenegenics-international/
or email Mario Garcia at
mgarcia@cenegenics.com
CONTACT INFORMATION
Mario Garcia
mgarcia@cenegenics.com
配信代行: JCN
Source: Cenegenics Elite Health
Copyright ©2025 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Release
CanSinoBIO Launches Pneumococcal Vaccine: An Innovative Choice to Safeguard Children's Health
Jun 20, 2025 19:06 JST
Sharp Launches A2 Size ePoster Color Electronic Paper Display
Jun 19, 2025 12:08 JST
Fujitsu unveils AI-powered presentation technology, enabling automated multilingual and customizable presentations
Jun 19, 2025 10:25 JST
ULVAC Continues Participation in "Lab-in-Fab" Project to Advance Piezoelectric MEMS Technology, Now Entering a New Phase
Jun 19, 2025 09:30 JST
NEC and Chugai Pharmaceutical use AI to potentially enhance cancer treatment
Jun 18, 2025 13:40 JST
Fujitsu awarded contract to design next-generation flagship supercomputer FugakuNEXT
Jun 18, 2025 11:35 JST
Honda Celebrates 60th Anniversary of First F1 Victory with Special Events Program
Jun 17, 2025 17:45 JST
MHI Receives Order to Supply 5 Models of Pumps, a Total of 34 Units, for Sizewell C Unit 1 and 2 in the UK from Trillium Flow Technologies
Jun 17, 2025 17:10 JST
Honda Teams to Compete in 2025 FIM Endurance World Championship "Coca-Cola" Suzuka 8 Hours Endurance Road Race 46th Tournament
Jun 16, 2025 16:37 JST
Fujitsu unveils Millimeter-Wave Monitoring System for enhanced safety and privacy in care facilities
Jun 16, 2025 16:20 JST
Tat Hong Equipment Service Co., Ltd. Announces 2024/25 Annual Results
Jun 13, 2025 22:49 JST
Yee Hop Holdings (1662.HK) Subsidiary APEL Launches Microfactory in Collaboration with HKPC
Jun 13, 2025 21:38 JST
Jacobson Pharma Announces FY2025 Annual Results
Jun 13, 2025 20:16 JST
TRENDE Announces Strategic Capital and Business Alliance with Tokyu Land
Jun 13, 2025 13:00 JST
Supercomputer Fugaku retains first place worldwide in Graph500 rankings
Jun 10, 2025 19:47 JST
International Consortium Rolls Out Major EV Battery Swapping Initiative in Tokyo
Jun 06, 2025 16:42 JST
TANAKA PRECIOUS METAL TECHNOLOGIES Receives 2025 Technology Award from Catalyst Manufacturers Association, Japan, for Development and Practical Application of Electrode Catalysts for PEM Water Electrolysis
Jun 06, 2025 11:00 JST
Fujitsu unveils Technology and Service Vision 2025: People-AI collaboration for a net positive future
Jun 06, 2025 10:44 JST
Alpha Growth plc: Alpha Alternative Assets Fund Update ("AAAF")
Jun 04, 2025 15:00 JST
MHI Thermal Systems Receives A' Design Awards
Jun 04, 2025 14:10 JST
More Latest Release >>